Find University Hospitals Doctors

Marina Magrey, MD

Marina Magrey, MD



Accepting New Patients

Schedule an Appointment


Are you pregnant or have you had a baby in the last 2 months?


  • Division Chief, Rheumatology, UH Cleveland Medical Center
  • Professor, CWRU School of Medicine

Marina Magrey, MD, is Division Chief of Rheumatology at University Hospitals Cleveland Medical Center and a Professor at Case Western Reserve University School of Medicine. After she received her medical degree from the University of Kashmir, India, Dr. Magrey completed an internal medicine residency and fellowship in rheumatology at the Cleveland Clinic.

Dr. Magrey's scholarship focuses on the management of axial spondyloarthritis, psoriatic arthritis and metabolic bone disease to improve outcomes in patients. Driven by her passion for providing high-quality, evidence-based care with cost containment, she developed a disease specific clinic for spondyloarthritis in a prior role at MetroHealth.

Nationally, Dr. Magrey is considered a thought leader in spondyloarthritis. She serves on the Board of Spondyloarthritis Research and Treatment Network (SPARTAN). Dr. Magrey is an invited member of both the Assessment in Spondyloarthritis International Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), which are study groups comprised of international experts in spondyloarthritis. Dr. Magrey is co-chair of the American College of Rheumatology (ACR) subcommittee for abstracts in axial spondyloarthritis, also serving on the ACR guideline subcommittee to develop guidelines for the treatment of psoriatic arthritis and glucocorticoid-induced osteoporosis.

Dr. Magrey is involved in clinical and translational research for biomarkers in spondyloarthritis and participates in clinical trials for spondyloarthritis treatment. She has served as principle investigator of multiple National Institutes of Health grants and international collaborative projects with 40 publications. Dr. Magrey serves as a consultant in spondyloarthritis clinical research to the pharmaceutical industry. She is also a consultant for the rational design of randomized controlled spondyloarthritis treatment trials, analysis of the results of such trials and the presentation of novel products for approval to the U.S. Food and Drug Administration.

Additionally, Dr. Magrey enjoys teaching. She served as the rheumatology fellowship training director at MetroHealth Medical Center. Presently, she serves on the education committee of SPARTAN and on the steering committee of Medscape CME and Education, spondyloarthritis section. She is also a board member of the Cleveland Society of Rheumatology.

Dr. Magrey has earned several honors and is consistently rated as one of the best rheumatologists in the country. Along with being a respected clinician and researcher, Dr. Magrey strongly believes in giving back to her community. She started the Salam Free Clinic, the first free clinic of its kind in the historically disadvantaged Hough neighborhood of Cleveland, Ohio. Beyond her work, Marina loves her family, especially her two sons. In her free time, she likes to go on walks, follow the news and watch the latest shows on Netflix.

Languages Spoken


Office Locations

CMC Mather Ste 1500

11100 Euclid Ave
Cleveland OH, 44106

UH Minoff Health Center at Chagrin Highlands

3909 Orange Pl
Beachwood OH, 44122

18181 Pearl Rd Bld B Ste 204

18181 Pearl Rd
Strongsville OH, 44136

Board Certifications

  • Rheumatology - American Board of Internal Medicine


Fellowship | Rheumatology
Rheumatology - Cleveland Clinic (2006 - 2008)

Residency | Internal Medicine
Internal Medicine - Cleveland Clinic (1994 - 1997)

Medical Education
University Of Kashmir (1991)

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Marina Magrey did not disclose any Outside Relationships with Industry.